1. Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients

British Journal of Biomedical Science, 2017, 74(4) p. 170

DOI: 10.1080/09674845.2017.1334739

Citations as recorded by:

2. MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis

Sci Rep, 2017, 7(1)

DOI: 10.1038/s41598-017-11351-5

Citations as recorded by:

3. Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis

Med Sci Monit, 2017, 23 p. 850

DOI: 10.12659/MSM.899198

Citations as recorded by:

4. Long noncoding RNAs as novel serum biomarkers for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis

Clin Transl Oncol, 2017, 19(8) p. 961

DOI: 10.1007/s12094-017-1626-1

Citations as recorded by:

5. Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients.

Br. J. Biomed. Sci.,

DOI: 1

Citations as recorded by:

6. MiRNA-target network analysis identifies potential biomarkers for Traditional Chinese Medicine (TCM) syndrome development evaluation in hepatitis B …

Year: 2017

Citations as recorded by:

7. Investigation of the roles of trace elements during hepatitis C virus infection using protein-protein interactions and a shortest path algorithm

Year: 2016

Citations as recorded by: